Optum brings together experts from across health care to share insights on the industry's response to COVID-19 in this FiercePharma webinar.
The COVID-19 pandemic has disrupted all facets of life, from how we spend time with loved ones to how we receive health care. In this on-demand webinar, panelists discuss:
- What real-world data (RWD) is telling us about the impact of COVID-19 on patient management and pharmaceutical management
- What real-time, RWD is telling us about the changing drug landscape such as clinical trials, HEOR, epidemiology and data science
- How a large payer is managing COVID-19 and its impact on overall medication use
- The impact of the national COVID-19 shutdown on pharmaceutical use and preventive office visits
Featured Speakers:
Mike Anderson, PharmD
Chief Executive Officer, Medicare Part D
UnitedHealthcare
Lou Brooks
Vice President, Commercial Analytics, Life Sciences
Optum
Brian Solow, MD, moderator
Chief Medical Officer, Life Sciences
Optum
Brian D. Bradbury, DSc
Vice President, Center for Observational Research
Amgen, Inc.
Kathleen Gondek, PhD
Global Head of Evidence and Outcomes
Takeda
Please complete the form to register for this webinar.